foxo4 dri senolytic 2023 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions
Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Cellular Senescence in Health, Disease, and Lens Aging Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26




